Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
about
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsTranscription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneTelomerase: The Devil InsideCRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseasesRoles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapiesReactivation of telomerase in cancerTERT promoter mutations in thyroid cancerThe search for cis-regulatory driver mutations in cancer genomesMutation Profile of Well-Differentiated Thyroid Cancer in AsiansCurrent status and future perspectives in differentiated thyroid cancerPersonalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsCIViC databaseBRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrenceDiagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy.Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerInhibition of telomerase recruitment and cancer cell deathTERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entitiesUpdate: the status of clinical trials with kinase inhibitors in thyroid cancerCorrelative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology GroupHobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinomaA meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinomaTERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumorsMicroRNA Deregulation in Anaplastic Thyroid Cancer Biology.Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.Molecular approaches to thyroid cancer diagnosis.TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomasTelomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.Enhancer alterations in cancer: a source for a cell identity crisis.Development and characterization of six new human papillary thyroid carcinoma cell lines.Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers.Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer.BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review.Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl
P2860
Q26738705-44BDE08D-3BCD-4D0E-8E57-94A0AE3991C6Q26739925-F3CB6962-EC9A-40BA-A875-05F4357AC84AQ26739948-EB465A18-2865-4990-B7DB-110985C85006Q26744172-84A7EA7F-CEED-407B-B2DE-65FBE7768E28Q26744271-28BB239E-988E-4282-A530-ED5AD74311E2Q26769014-231C4A27-9D04-4825-A62C-B9A7E25D4991Q26770808-218349DC-900A-453B-83CE-E58BD2E17108Q26781886-C32E264E-3B4E-4DBE-93EA-8DB0B35DD5B4Q26782322-85F8E36B-064D-4D81-A979-62459CEEAC2DQ27024484-366DF289-7E7C-448B-8368-0353D5B616A5Q27027491-EFF9CB16-1F46-4649-A882-9AE8CA826D69Q27612411-3DA07399-83CC-4742-95F0-5FC43E3C13D5Q27853042-F92933C6-C2B4-476A-92C8-DD5210089877Q27853057-3060D295-3307-4390-8327-F6794285C80AQ28394370-C3BD5F31-712B-4AC1-9C70-9EDEF85ED165Q30367068-D7A5CB56-1F64-4927-BA9C-E57D20D9757EQ30457044-A7789BAA-5FF1-417E-A3CF-CA274064AE5EQ33414576-6329A90F-7115-48D1-8BF1-95769F61661AQ33570056-0BBCBC8A-1BAE-47BC-AE69-E426DD68025FQ33587905-EA0C8115-C0BD-4EFE-A9F0-0ED0CB24A504Q33591794-6A38565A-BD58-41FD-86D3-4A5C48784A42Q33656624-EA890F70-14BD-4C0C-98A1-2490897F0394Q33682388-529701CF-F4C8-450D-9B12-E0AC465C6DF7Q33688439-D602F393-0A78-42F6-8633-E76EBCCE5CB8Q33709979-9C749544-097F-4930-B70E-A94C785F1B3AQ34119098-68E4249B-A003-4500-9604-0620CE7484FFQ34152070-18139FEC-BD72-48FB-B7D8-7C20CA45C6BBQ34160828-59A86E2A-7A5E-45B5-8BD7-D5304FEE8649Q34313648-E407F4B8-F20B-46E3-A024-F1E8DDC8B19EQ34396480-AD180A28-9C73-4B6B-95A4-9D3A961EF9C9Q34624854-3D10448D-26AF-4F0B-91F2-3F0210080A63Q35055107-C3D147DD-261B-44D9-8F4E-E5BCB7D548C3Q35441872-ED4D04DF-DD2C-4C98-9BF7-63C1714CD043Q35554680-C445B03B-CB89-4940-9332-646A35DEF73FQ35857790-AA46109E-8E98-444A-A3DB-A065C9F17BACQ35906046-B06C53F5-37EC-42FF-8739-E535554E06C9Q35985808-4C31B5D0-9FD4-4CF6-AC4F-A972DE279A5AQ36014228-8CB30222-ED9F-41D5-AB9A-6C6EBD29C42DQ36221232-F0101E92-8922-4047-BDE7-CC696E4ACC8FQ36301491-344B212C-3596-4C01-B4CD-ACE31247814F
P2860
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@ast
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@en
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@nl
type
label
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@ast
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@en
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@nl
altLabel
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
@en
prefLabel
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@ast
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@en
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@nl
P2093
P2860
P3181
P356
P1476
Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
@en
P2093
Adel K El-Naggar
Avaniyapuram Kannan Murugan
Dingxie Liu
Justin Bishop
Mingzhao Xing
Xiaoli Liu
P2860
P304
P3181
P356
10.1530/ERC-13-0210
P577
2013-08-01T00:00:00Z